Phillip Andrew Dennis Sells $5.83K of NovaBridge Biosciences (NBP) — SEC Form 4, Sep 21, 2026
Open-Market Net Sale · SEC Form 4
−$5,828
Equity position changed by +9.3%
Equity Position
182K sh
166,150 → 181,636
Equity Change
+9.3%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Phillip Andrew Dennis CIK 0002089237 |
Officer
|
Phillip Andrew Dennis at NovaBridge Biosciences
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$11,434
More from this insider at NovaBridge Biosciences
| 2026-06-22 | Sell | -$5,606 | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
Footnotes (9)
- F1
- The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
- F2
- Reported securities are represented by 10,302 ADSs. Show more
- F3
- Each restricted stock unit ("RSU") represents a contingent right to receive one ADS. Show more
- F4
- Reported securities are represented by 78,972 ADSs. Show more
- F5
- Reported securities are represented by 3,569 ADSs. Show more
- F6
- Reported sales price represents the converted sales price of the ADSs of $1.6247. Show more
- F7
- Reported securities are represented by 75,403 ADSs. Show more
- F8
- Reported securities represent ADSs. Show more
- F9
- On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month. Show more
Related filings at NovaBridge Biosciences
Institutional Holders
13F holders · Sep 30, 2026
47
institutional managers reporting a position
Largest by reported value
- Hhlr Advisors, Ltd. $8.16M
- Morgan Stanley $4.74M
- Aihc Capital Management Ltd $3.93M
5%+ Holders · 13D/G
3 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at NovaBridge Biosciences
GET /v1/forms/4/0002089237-26-000008
API docs
View Original SEC Filing